insulin aspart
| Brand name | Novolog |
|---|---|
| Active ingredient | insulin aspart |
| Strength | 1,000UNITS/10ML (100UNITS/ML) |
| Dosage form | Injection |
| Route | Intravenous, Subcutaneous |
| Modality | Biologic |
| FDA approval | June 2000 |
| Marketing status | Rx |
Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.